Of note, the high serum p-tau 181 and p-tau 217 levels in ALS participants from the Halle cohort compared to other cohorts may be explained by our finding of an association between biomarker levels and disease duration at blood sampling and the longer disease duration of ALS patients in this cohort. Here, MAPT is linked to amyotrophic lateral sclerosis.